Trying to figure out how to pick between the Ambulatory Specialty Model (ASM) and other QPP options? With all the changes in Medicare reporting, it can feel like the rules shift every year. If you’re practicing in a specialty or just want to make sure you’re ready for what’s coming, understanding the differences is key. This article breaks down what you need to know about programs within QPP and ASM, and how to make the right choice for your practice.
Key Takeaways
- MIPS Value Pathways (MVPs) within the Quality Payment Program (QPP) let you pick measures that fit your specialty, while ASM has set measures for certain conditions.
- ASM will be mandatory for specific specialties and locations, so check if you could be included.
- Reporting either MIPS or MVPs under QPP can help you prepare for future rules and may improve your scores if you start early.
- ASM uses peer individual performance comparison, so you’re directly compared to others treating the same condition.
- If you want more control and flexibility, QPP options like MVPs or MIPS might be better now, but ASM could become unavoidable for some.
Understanding the QPP Framework
The MIPS Value Pathways (MVPs) represent a shift toward tailored performance measurement within the QPP by bundling specialty-relevant measures.This approach streamlines evaluations and supports targeted quality improvements.
During this transition, providers can test MIPS and MVPs to find the best scoring strategy. Such flexibility allows diverse practices to highlight performance via specialized reporting.
The QPP framework aligns with value-based care by emphasizing population health and shared accountability. This shift prioritizes specialty relevance and patient outcomes in future quality reporting.
Key Differences: MVP Pathways Versus Traditional MIPS
MIPS Value Pathways (MVPs) were created to fix traditional MIPS issues. By offering structured, specialty-specific frameworks, MVPs better reflect real-world care delivery. Understanding these differences helps organizations adapt to the changing landscape of quality reporting.
How MVPs improve on traditional MIPS:
- Streamlined quality measure selection: Reduces the required measures from six in traditional MIPS to a smaller, pre-defined set, typically four, that are aligned with a specific clinical pathway, making reporting more relevant.
- More accurate cost accountability: Limits cost evaluation to measures within the selected pathway, ensuring clinicians are assessed on costs they can realistically influence, unlike MIPS’s broad attribution rules.
- Reduced reporting burden: Bundles quality, cost, improvement activities, and promoting interoperability into a single, cohesive structure to simplify workflows and allow practices to focus on fewer, more targeted requirements.
As CMS continues to move toward pathway-based reporting, MVPs serve as a bridge between traditional MIPS and more advanced value-based models, helping practices align quality measurement with specialty-driven care.
Introducing the Ambulatory Specialty Model (ASM)
CMS is launching the Ambulatory Specialty Model (ASM) from 2027 to 2031 to improve specialist accountability for conditions like heart failure and low back pain. It uses mandatory, peer-based performance assessments within specific specialties and geographic regions.
Comparing ASM and Other QPP Options
As CMS expands value-based care pathways, understanding how the Ambulatory Specialty Model (ASM) differs from other QPP options is critical. While both aim to align quality reporting with clinical practice, ASM takes a more standardized and directive approach, reflecting its role as a mandatory, condition-based payment model rather than a flexible reporting option.
How ASM differs from other QPP options:
- Universal, condition-specific measures: ASM requires reporting on a fixed set of quality measures for targeted conditions like heart failure and low back pain, ensuring consistent evaluation across all participants.
- Less flexibility, greater standardization: Unlike other QPP pathways, ASM uses uniform performance expectations to allow for direct peer-to-peer comparisons within the same condition and region.
- Designed as an Advanced Payment Model: ASM is an APM itself rather than just a bridge, involving increased financial risk and reward compared to traditional QPP reporting.
Together, these differences highlight ASM’s role as a testing ground for condition-based specialty payment models and a signal of CMS’s broader shift toward standardized, outcomes-driven reimbursement.
Evaluating Participation and Performance
How you participate in QPP, and soon, models like the Ambulatory Specialty Model, shapes not only your reporting workload but your final Medicare payment adjustments. With new frameworks becoming available, understanding what participation actually looks like can help you make informed choices for your practice.
Current QPP Participation Trends
In the 2023 performance period, roughly less than 10% of MIPS clinicians registered for an MVP, though far fewer used it for their final score. Many providers opted to report via multiple methods, allowing CMS to select their highest result. This cautious approach reflects the challenges of transitioning to new frameworks before results are fully proven.
Impact of MVP Reporting on Scores
When it comes to performance, MVPs can actually boost scores for some. In 2023, those clinicians who got their final score from MVP reporting performed better on average compared to traditional MIPS. Median scores were higher, with MVP-based scores clustering near the upper 80s.
Key takeaways:
- Choosing MVPs can lead to higher scores, but only if your data fits the chosen pathway.
- Most dual-reporters ended up with a higher MVP score
- Scoring methods continue to adjust, so staying current matters if you’re aiming for better outcomes.
Preparing for Future Model Expansions
Change is coming, and MVPs and ASM may not be optional much longer. Here are steps to get ready:
- Track annual rule changes, requirements may shift unexpectedly, and what’s voluntary today could be required soon.
- Analyze your current population health and cost reporting, find weak spots, and think about how your practice would be scored in a peer-only group.
- Try piloting MVP or ASM reporting internally before you must do it for CMS. That way, you learn the workflow before penalties are real.
Continually compare current reporting to new models. Early adjustments facilitate a smoother transition and reduce future stress. ASM and MVP participation will grow as CMS replaces legacy programs. Assessing your participation now ensures reliable performance in the coming years
Understanding how well everyone is doing and how much they’re contributing is key. We help you track this so you can see the full picture. Want to learn more about how we measure success? Visit our website today!
Conclusion
Choosing between the ASM and other QPP pathways doesn’t have to be overwhelming. Since CMS is moving the entire industry in this direction, the real question is: which path aligns with your practice’s DNA? Consider your historical performance and where you might already be facing mandates. While ASM offers less reporting flexibility, it provides a much fairer ‘apples-to-apples’ peer comparison for specialists. Other QPP pathways allow you more control over what you highlight/submit to CMS, but they often lack that clinical precision when compared to others’ performances. The key is to start exploring these options now while you still have the lead time to test and adjust. If you’re unsure where to begin, a reporting vendor or trusted advisor can help you map out the most sustainable route.
